Autonomous driving technology developer MaxiEye bagged nearly $50m in a Desay-led round while software testing technology producer Mabl raised $40m from investors including GV and Presidio Ventures.

Koch Disruptive Technologies helped molecular diagnostics system developer Sense Biodetection expand its latest round to $65m while Hilti bought portfolio company Fieldwire for $300m.

The voice intraction technology provider, which counts a host of corporates among its investors, will get a Nasdaq listing through the transaction.

Citi has exited neobanking software developer Digit and real estate analytics provider Reonomy in acquisitions each sized at over $200m.

Oncology therapy developer Recludix Pharma raised $60m in an Access Biotechnology-backed round while Stripe took part in digital payment technology developer Imprint's $38m series A.

The Volkswagen and Access Industries-backed ride-hailing service joined forces with Rosecliff Acquisition Corp I in a deal valuing the combined company at $1bn.

The Intel and Recruit-backed hospitality technology developer is set to gain a Nasdaq listing through the transaction.

Bristol Myers Squibb and Pfizer Ventures are part of a PIPE financing backing the fibrosis and neurodegenerative disease drug developer's reverse takeover.

UTEC is celebrating an exit as Agara is acquired by Coinbase for a reported $40m to $50m.

Johns Hopkins spinout Blade Therapeutics has agreed to a reverse merger that will net it $24.3m in Pipe financing from backers including Osage University Partners.